A double-blind, placebo controlled cross-over trial of adjunction of donepezil to atypical antipsychotics for cognitive impairment in schizophrenia

被引:0
|
作者
Niknam, Z. [1 ]
Fadaii, F. [1 ]
机构
[1] Univ Social Welf & Rehabil, Tehran, Iran
关键词
D O I
10.1016/S0022-510X(09)71067-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S280 / S281
页数:2
相关论文
共 50 条
  • [41] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Bayer, Otmar
    Bremova, Tatiana
    Strupp, Michael
    Huefner, Katharina
    JOURNAL OF NEUROLOGY, 2018, 265 (02) : 291 - 298
  • [42] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
    Jose Luis López-Sendón Moreno
    Juan García Caldentey
    Patricia Trigo Cubillo
    Carolina Ruiz Romero
    Guillermo García Ribas
    M. A. Alonso Alonso Arias
    María Jesús García de Yébenes
    Rosa María Tolón
    Ismael Galve-Roperh
    Onintza Sagredo
    Sara Valdeolivas
    Eva Resel
    Silvia Ortega-Gutierrez
    María Laura García-Bermejo
    Javier Fernández Ruiz
    Manuel Guzmán
    Justo García de Yébenes Prous
    Journal of Neurology, 2016, 263 : 1390 - 1400
  • [43] A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss
    Devi, Gayatri
    Massimi, Steve
    Schultz, Sarah
    Rhosrowshahi, Lynn
    Laakso, Ulla K.
    GENDER MEDICINE, 2007, 4 (04) : 352 - 358
  • [44] A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study
    Ridha, Basil H.
    Crutch, Sebastian
    Cutler, Dawn
    Frost, Christopher
    Knight, William
    Barker, Suzie
    Epie, Norah
    Warrington, Elizabeth K.
    Kukkastenvehmas, Riitta
    Douglas, Jane
    Rossor, Martin N.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [45] A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study
    Basil H. Ridha
    Sebastian Crutch
    Dawn Cutler
    Christopher Frost
    William Knight
    Suzie Barker
    Norah Epie
    Elizabeth K. Warrington
    Riitta Kukkastenvehmas
    Jane Douglas
    Martin N. Rossor
    Alzheimer's Research & Therapy, 10
  • [46] A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss
    Devi, Gayatri
    Massimi, Stephen
    Schultz, Sarah
    Khosrowshahi, Lynn
    Laakso, Ulla K.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1094 - 1094
  • [47] Evaluation of daytime sleepiness in patients with schizophrenia treated with atypical antipsychotics: Results from a randomized, double-blind, placebo-controlled trial
    Loebel, A.
    Siu, C.
    Cucchiaro, J.
    Pikalov, A.
    Harvey, P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 146 - 146
  • [48] Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: A double-blind, placebo-controlled study
    Fagerlund, Birgitte
    Soholm, Bettina
    Fink-Jensen, Anders
    Lublin, Henrik
    Glenthoj, Birte Y.
    CLINICAL NEUROPHARMACOLOGY, 2007, 30 (01) : 3 - 12
  • [49] Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: A double-blind, placebo-controlled study
    Fagerlund, B.
    Soholm, B.
    Fink-Jensen, A.
    Lublin, H.
    Glenthoj, B. Y.
    NORDIC JOURNAL OF PSYCHIATRY, 2006, 60 (04) : 329 - 330
  • [50] Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial
    Bruera, Eduardo
    El Osta, Badi
    Valero, Vicente
    Driver, Larry C.
    Pei, Be-Lian
    Shen, Loren
    Poulter, Valerie A.
    Palmer, J. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3475 - 3481